Union Minister for Health and Family Welfare, Shri Jagat Prakash Nadda, launched the Annual Nationwide Mass Drug Administration (MDA) Campaign to eliminate Lymphatic Filariasis (LF). The campaign, introduced via video conference with State Health Ministers and senior officials from 13 endemic states, reinforces India’s commitment to eradicating LF by 2027.
The MDA campaign, a key strategy under the National Center for Vector Borne Diseases Control (NCVBDC), focuses on door-to-door administration of anti-filarial medicines. Covering 111 endemic districts across 13 states, the campaign ensures that every eligible individual takes the prescribed medication to curb transmission. LF, commonly known as “Hathi Paon,” is a mosquito-borne parasitic disease that can cause severe disabilities, including lymphoedema and hydrocele.
Shri Nadda emphasised the importance of community participation, stating, “An LF-free India is our commitment, and achieving this goal requires the active involvement of every citizen.” He reiterated that the campaign, starting from 10 February, will provide free medication to over 17.5 crore people in endemic districts. The target is to ensure that at least 90% of the eligible population consumes the medicine to break the disease transmission cycle.
The Union Health Minister also outlined a five-pronged strategy to eliminate LF ahead of the Sustainable Development Goal (SDG) target of 2030. He urged states to monitor the campaign at the district level, stressing the need for political and administrative leadership to oversee implementation.
Highlighting the role of digital technologies, Shri Nadda praised Uttar Pradesh and Odisha for effectively using digital tools in health awareness campaigns. He encouraged other states to adopt similar initiatives to maximise outreach. He also called for broader inter-ministerial collaboration and engagement with elected representatives, including Members of Parliament, Legislative Assemblies, and Panchayati Raj Institutions, to mobilise communities.
Efforts continue to integrate Morbidity Management and Disability Prevention (MMDP) services into Ayushman Arogya Mandir (AAM) facilities. Approximately 50% of lymphoedema cases receive MMDP kits annually, and hydrocelectomy surgeries receive support under the National Health Mission (NHM) and PMJAY schemes. Shri Nadda noted that nearly 50% of hydrocele surgeries were conducted in endemic states in 2024, significantly reducing the disease burden.
Concluding his address, the Minister reaffirmed India’s unwavering commitment to eliminating LF, calling it the “last mile challenge.” He urged health workers to focus on targeted areas, ensuring every affected individual receives care. “India has and will continue to remain steadfast in its resolve to eliminate Lymphatic Filariasis. Our target is to achieve this goal by 2027,” he stated.
